跳至主要内容
临床试验/NL-OMON32443
NL-OMON32443已完成3 期

Echocardiography Guided Cardiac Resynchronization Therapy Clinical Investigation - EchoCRT

BIOTRONIK Inc. - clinical study department0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • indication for ICD
  • systolic heart failure: LVEF < 35% and LVEDD > 55 mm
  • NYHA III-IV under optimal medical therapy
  • QRS < 130 ms
  • ventricular dyssynchrony measured by Echo + confirmed by Echo Core Lab
  • 18 years of age or older

排除标准

  • Contraindication(s) to an ICD.
  • Already implanted with a pacemaker or an ICD
  • Bradycardia pacing indication
  • Pregnant, lactating or planning to become pregnant females.
  • CABG, PTCA, or MI within the past 3 months prior to enrollment or CABG or PTCA intervention planned in the next 3 months.
  • Irreversible brain damage from preexisting cerebral disease.
  • Reversible non-ischemic cardiomyopathy such as acute viral myocarditis.
  • Permanent 2º or 3º heart block.
  • Chagas disease.
  • Persistent, permanent, or paroxysmal atrial fibrillation within 1 month prior to enrollment.
  • Expected to receive heart transplantation within 6 months.
  • Have a life expectancy of less than 6 months
  • Creatinine > 2.5 mg/dL or liver failure

研究者

发起方
BIOTRONIK Inc. - clinical study department

相似试验